[HTML][HTML] Strategies for heterologous expression, synthesis, and purification of animal venom toxins

E Rivera-de-Torre, C Rimbault, TP Jenkins… - … in bioengineering and …, 2022 - frontiersin.org
Animal venoms are complex mixtures containing peptides and proteins known as toxins,
which are responsible for the deleterious effect of envenomations. Across the animal …

Anti-hyperuricemia bioactive peptides: a review on obtaining, activity, and mechanism of action

K Wang, Y Wang - Food & Function, 2024 - pubs.rsc.org
Hyperuricemia, a disorder of uric acid metabolism, serves as a significant risk factor for
conditions such as hypertension, diabetes mellitus, renal failure, and various metabolic …

Towards toxin PEGylation: The example of rCollinein-1, a snake venom thrombin-like enzyme, as a PEGylated biopharmaceutical prototype

EL Pinheiro-Junior, J Boldrini-França… - International Journal of …, 2021 - Elsevier
PEGylation was firstly described around 50 years ago and has been used for more than 30
years as a strategy to improve the drugability of biopharmaceuticals. However, it remains …

Recombinant Expression in Pichia pastoris System of Three Potent Kv1.3 Channel Blockers: Vm24, Anuroctoxin, and Ts6

J Borrego, MU Naseem, ANA Sehgal, LR Panda… - Journal of Fungi, 2022 - mdpi.com
The Kv1. 3 channel has become a therapeutic target for the treatment of various diseases.
Several Kv1. 3 channel blockers have been characterized from scorpion venom; however …

Different Strategies for the Biosynthesis of Bioactive Peptide Using Bioengineering Technology in Pichia pastoris: A Review

K Hong, Y Rong, Y Jiang, J Yuan, F Wu, L Gao… - Food and Bioprocess …, 2025 - Springer
Bioactive peptides (BPs) derived from proteins in food possess significant potential as
functional food ingredients. Traditional enzymatic hydrolysis is often constrained by raw …

Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes

L di Leandro, M Colasante, G Pitari, R Ippoliti - Toxins, 2023 - mdpi.com
The production of therapeutic recombinant toxins requires careful host cell selection.
Bacteria, yeast, and mammalian cells are common choices, but no universal solution exists …

Examining the interactions scorpion venom peptides (HP1090, Meucin-13, and Meucin-18) with the receptor binding domain of the coronavirus spike protein to design …

K Mahnam, M Lotfi, FA Shapoorabadi - Journal of molecular graphics and …, 2021 - Elsevier
The spike protein of SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus 2)
interacts with the ACE2 receptor in human cells and starts the infection of COVID-19 …

The complex repertoire of Tityus spp. venoms: Advances on their composition and pharmacological potential of their toxins

GA Wiezel, IS Oliveira, MB Reis, IG Ferreira… - Biochimie, 2024 - Elsevier
Animal venoms are a rich and complex source of components, including peptides (such as
neurotoxins, anionic peptides and hypotensins), lipids, proteins (such as proteases …

Efficient heterologous expression in Pichia pastoris, immobilization and functional characterization of a scorpion venom secreted phospholipase A2

N Krayem, R Sidhoum, S Cherif, A Karray - Toxicon, 2022 - Elsevier
Industrial processes have expanded with the ability to clone and express recombinant
immobilized enzymes in microorganisms such as Pichia pastoris that have commercially …

Expression and purification of recombinant alpha-toxin AnCra1 from the scorpion Androctonus crassicauda and its functional characterization on mammalian sodium …

MA Bayatzadeh, A Zare Mirakabadi, N Babaei… - Molecular Biology …, 2021 - Springer
Background Alpha-scorpion toxins with long-chain peptide and four disulfide bonds
represent diverse pharmacological profiles for various subtypes of voltage-gated sodium …